"Pros and cons" on how to measure multidrug resistance in leukemias.
about
Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters FunctionCaspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications.Nature and uses of fluorescent dyes for drug transporter studies.Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.
P2860
"Pros and cons" on how to measure multidrug resistance in leukemias.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
"Pros and cons" on how to measure multidrug resistance in leukemias.
@ast
"Pros and cons" on how to measure multidrug resistance in leukemias.
@en
"Pros and cons" on how to measure multidrug resistance in leukemias.
@nl
type
label
"Pros and cons" on how to measure multidrug resistance in leukemias.
@ast
"Pros and cons" on how to measure multidrug resistance in leukemias.
@en
"Pros and cons" on how to measure multidrug resistance in leukemias.
@nl
prefLabel
"Pros and cons" on how to measure multidrug resistance in leukemias.
@ast
"Pros and cons" on how to measure multidrug resistance in leukemias.
@en
"Pros and cons" on how to measure multidrug resistance in leukemias.
@nl
P2093
P2860
P1433
P1476
"Pros and cons" on how to measure multidrug resistance in leukemias.
@en
P2093
Béla Telek
Eva Karászi
János Kappelmayer
Katalin Jakab
P2860
P304
P356
10.1080/10428190290016791
P577
2002-04-01T00:00:00Z